Abstract
Original Article
Year: 2011 | Volume: 2 | Issue: 2 | Page No: 181-185
Source of Latest Anti-TB Treatment amongst Re-treatment TB Cases Registered Under RNTCP in Gujarat
Author: P Dave, K Rade, KR Pujara, R Solanki, B Modi, PG Patel, P Nimavat
Affiliation:
Abstract:
Introduction: Despite sustained performance in case detection and success rate under Revised
National TB Control Programme for >5 years, higher proportion of re-treatment cases has been
observed amongst smear positive cases in Gujarat.
Objective: To find out the source of re-treatment TB cases registered for treatment under DOTS under
RNTCP to indirectly estimate role of private sector in treating TB patients.
Methods: Cross-sectional study. Review of records and reports & data from TB treatment cards was
compiled and analyzed (Secondary data source)
Results: Proportion of re-treatment cases having latest type of anti-TB treatment under DOTS were
63% as compared to 37% of non-DOTS regimens. Amongst those who had received DOTS as latest
treatment re-treatment registration as relapse was highest with 58% while it was Treatment After
default with 44% as highest proportion amongst those with non-DOTS as latest anti-TB regimens.
There was high correlation between the type of registration of re-treatment in the year 2010 and the
outcomes reposted for year 2009 cohorts under DOTS for treatment after default and failures. There is
a definite negative correlation between ratio of DOTS : non-DOTS as latest regimen history amongst
the re-treatment TB cases registered and the New Smear Positive TB case registrations.
Conclusion: Though RNTCP has achieved programme objectives at state level since more than 5
years in Gujarat, there exists a huge case load of Tuberculosis in private sector. Higher proportion of
relapse registrations from DOTS sources can be attributed to high number of patients successfully
treated on previous occasions. Default still is the major concern in non-DOTS regimens.
Keywords: DOTS, RNTCP, private sector, source of anti-TB treatment
DOI:
NJCM is licensed under Creative commons(CC BY-SA 4.0) International
Online Users
0